Abstract: Cancer related anemia (CRA) is one of the ancer complications. The incidence rate of CRA is more than 70% in patients after receiving chemotherapy, radiation therapy, or both. CRA has severe clinical symptoms which significantly attenuate effectiveness of cancer treatment and the quality of patients′ life. The current treatments for CRA, such as transfusion, recombinant EPO therapy, iron supplement and so on, could correct CRA in some sense. However, the present accepted therapeutic approaches could not be satisfied since there are complexity and diversity factors accounting for CRA. More effective and safety treatments of CRA are required in the near future.

Key words: Neoplasms, Anemia, Erythropoietin